1LohningM,StroehmannA,CoyleAJ,etal.T1/ST2ispreferen tiallyexpressedonmurineTh2cells,independentofinterleukin4,interleukin5,andinterleukin10,andimportantforTh2effectorfunction. Proceedings of the National Academy of Sciences of the United States of America . 1998
2Sweet MJ,Leung BP,Kang D,et al.A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of tolllike receptor 4 expression. J Immunol . 2001
3Zatloukal K,Schneeberger A,Berger M,et al.Elicitation of a systemic and protective anti-melanoma immune response by an IL-2based vaccine.Assessment of critical cellular and molecular parameters. J Immunol . 1995
4Mackey MF,Gunn JR,Ting PP,et al.Protective immunity induced by tumor vaccines requires interaction between CD40 and its ligand, CD154. Cancer Research . 1997
5Yamazaki K,Yano T,Kameyama T,et al.Clinical significance of serum TH1/TH2 cytokines in patients with pulmonary adenocarcinoma. Journal of Surgery . 2002
6Oshikawa K,Yanagisawa K,Ohno S,et al.Expression of ST2 in helper T lymphocytes of malignant pleural effusions. American Journal of Respiratory and Critical Care Medicine . 2002
7Asselin Paturel C,Echchakir H,Carayol G,et al.Quantitative analysis of Th1, Th2 and TGF-B1 cytokine expression in tumor,TIL and PBL of non-small cell lung cancer patients. International Journal of Cancer . 1998
8Ito N,Nakamura H,Tanaka Y,et al.Lung carcinoma: analysis of helper type 1 and 2 cells and T cytotoxic type 1 and 2 cells by intracellular cytokine detection with flow cytometry. Cancer . 1999
9Mattes J,Hulett M,Xie W,et al.Immuno therapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6dependent process. The Journal of Experimental Medicine . 2003
10Knutson KL,Disis ML.IL-12 enhances the generation of tumour antigen-specific Th1 CD4 T cells during ex vivo expansion. Clinical and Experimental Immunology . 2004
